UCB’s core antibody discovery platform


UCB’s core antibody discovery platform combines high-throughput B cell culture screening, and the identification and isolation of single, antigen specific IgG-secreting B cells through a proprietary technique called the ‘fluorescent foci method’. Using state of the art automation to facilitate screening , extremely efficient interrogation of the natural antibody repertoire is made possible; in fact, more than one billion immune B cells can now be screened to identify therapeutic antibody candidates.

This poster will describe our core antibody discovery process and focus on the integration of our bespoke automation system to provide efficiency savings and improvements in antibody quality. It will also highlight how we are developing our screening capabilities to allow for more complicated multiplex assays, allowing us to identify multiple binding profiles of antibodies in a single experiment.

Hosted By

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Follow us on Twitter

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG,, Labhoo Ltd 2003-2021